Summary
Teriparatide is absorbed across the nasal mucosa in two animal models, paving the way for a Phase 1 clinical trial to begin in late 2013. This article presents preclinical data of nanoenabled intranasal teriparatide for the treatment of osteoporosis.
- Diabetes & Endocrinology Clinical Trials
- Metabolic Bone Disease
- Hormone Therapy
- Diabetes & Endocrinology Clinical Trials
- Metabolic Bone Disease
- Hormone Therapy
- Endocrinology
- Diabetes & Metabolic Syndrome
- © 2013 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.